Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-22

Clinical Trial Update: A Open-label, Drug Interaction Study Between Eslicarbazepine Acetate and Topiramate [Phase 1]

View source ↗

Summary

Open-label Phase 1 trial evaluating the drug interaction between eslicarbazepine acetate and topiramate in epilepsy; the study has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topiramate (Topiramate)
  • eslicarbazepine acetate (eslicarbazepine acetate)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Epilepsy | Phase 1 | Status: COMPLETED | Results posted: 2014-12-22